Radiation therapy is a treatment that uses high doses of radiation to damage cancer cells, either killing them or slowing their growth. Unlike the low-dose radiation used in X-rays to see inside the ...

Patients with multiple myeloma exhibiting poor prognostic features, such as high-risk cytogenetics, soft-tissue plasmacytoma, ISS stage III disease, and triple-class exposure, experienced significant ...

Multiple myeloma is a cancer of plasma cells, the antibody-making white blood cells that live in your bone marrow. When these cells turn abnormal and multiply, they crowd out healthy blood-forming ...

In patients with extramedullary plasmacytoma of the head and neck, radiotherapy and surgery provide comparable survival outcomes, but radiotherapy significantly reduced the risk for progression to ...

The United States is becoming older, more diverse, and more overweight, and these changes may influence future trends in certain hematological cancers. A recent study examining trends in incidence ...

This panel featured Saad Z. Usmani, MD, MBA, with Carlyn Rose Tan, MD; Neha S. Korde, MD; and Kenny Capps from Throwing Bones. Usmani: My first question here is for Dr. Korde. Should first-degree ...

What Is Refractory Multiple Myeloma? Multiple myeloma is a cancer that affects a type of white blood cell called a plasma cell, which helps your immune system fight infections. Refractory means your ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

A 17-year-old girl presented to a hospital orthopedics department in Vietnam due to pain in her left hip joint, which she noted had been getting worse over the past month. Neither her personal nor her ...

Many doctors refer to late-stage multiple myeloma as stage III. This is the stage you’re most likely to be in when doctors diagnose you. It’s hard to find it early since it may start with no symptoms.